Friday, October 25, 2013

CURE ALL IN A NUTSHELL

Why is there a need for Cure All?

Since the advent of antibiotics (1928), we have not developed a single cure but management systems.

Alexander Fleming, discovered Penicillin in 1928. However it was not mass produced till 1934 where it could have saved millions more.  

What is The Cure All Foundation?

We are a community consisting of Patients and their Families along with professionals from the widest spectrum of disciplines. Together we volunteer our time (in other words, none of us get paid, EVER) to strive for “a world where patients are empowered to cure.”

What are the Barriers to Research?

Money, Politics and Information are Bottlenecks. We know this because:

v  Patients inflicted by illness wait tirelessly for a cure. Yet the forces influencing the pace of research are out of bounds from the sick. Patients have no say.
v  Scientists are working tirelessly for solutions, yet politics and funding constraints have decelerated progress. In the US, researchers spend 40+ percent of their time applying for grants.
v  Institutions do not appropriate funding to researchers efficiently and effectively. The middleman, entrusted, has become the primary consumer of research funding.
v  Researchers don’t share enough; they don’t talk to one another enough to distribute findings effectively. In a world social media, Facebook and Twitter, there is no equivalent in communication amongst the healing professions.

How do we plan to resolve the problem?

v  Bring SCIENTIST TOGETHER WITH PATENTS, ELIMINATE THE MIDDLEMAN.
v  Empower Patients and their families through:
  1.  Information – Learn about research being conducted, where, how and why.
  2.  Empower – Choose to follow, contact and fund research directly.
  3.  Control – Define the Cure from your perspective.

v  Empower Scientists
  1. Support – Receive financial and moral resources anywhere.
  2. Audience – Share information and learn directly from patients.
  3.  Mobility – Move anywhere conducive to research and still receive funding.
  4. Community – “Follow” other researchers and share to cure.

When will the solution start being effective?

Donations will be effective instantaneously. By rewarding good researchers, we will surely accelerate the pace of research immediately.

The Cure All platform will be Launched effectively Nov 30th 2013. 
Please visit us at WWW.CUREALL.ORG

Monday, October 14, 2013

Why We Fail to Cure?

Ask yourself, do you know anyone with a chronic disease? When was a “cure” last developed?

If you can’t remember, it’s ok, most of us weren't around in 1928. Once upon a time, in the year 1928, Alexander Fleming discovered the potential of Penicillin and its ability to treat and cure bacterial infections. Since then, pathologies are being managed. Take Malaria for example, it killed 660,000 in 2010. Diabetes, Cancer, AIDS, Multiple Sclerosis and ALS, just to name a few, kills progressively today and every day.

Our strategy of management has cost societies by draining resources away from nutrition, education and social amenities. The cost of Diabetes is in excess of $500 billion for the United States. This expense will reach one trillion by 2020. The cost to manage chronic diseases, in the US and elsewhere, is not sustainable.

If you are like me, you know the costs are not monetary only. Management alone compromises the quality of life for the sick and their families. Burdening them psychologically, physically and monetarily.  

There is no singularity in explaining social failures to cure. But there are certainly factors worth considering.

·       Nationally, scientists spend over 40% of their time applying for funding rather than conducting research. This funding process is trivial and politically charged.
·       The sequestration of the 2011 Budget Act has eliminated over a billion dollars for scientific research.
·       The majority of Non-Profits are inefficient in appropriating research funding. A simple web search would identify CEOs of Non Profits with salaries from the hundreds of thousands to millions.
·       In the United Sates, it costs $750 million to $1.5 billion to bring a drug to market.
·       Information bottlenecks/protectionism plagues science. In a world of Facebook and Twitter, researchers continue to operate in isolation. Unlike the rest of us, researchers do not tweet or “Like” one another’s work. Annual conferences and monthly or quarterly journals continue to serve as information conduits.



The global healthcare establishment has failed its true stakeholders, the patients, family and researchers who have dedicated their lives to heal.